Answers are grounded in this paper and cite their sources.
Here, a machine‐learning surrogate is developed for an FTO/TiO 2 /RbGeI 3 /Spiro‐OMeTAD/Au configuration from a Sobol‐sampled dataset of 4396 SCAPS‐1D simulations across seven absorber parameters. Comparison of model architectures demonstrates that power conversion efficiency (PCE) prediction accuracy, measured by R 2 , improves from 0.764 for ridge‐regularized linear regression to 0.879, 0.927, and 0.968 for second‐degree, third‐degree, and gradient boosting formulations, respectively. Sobol sensitivity analysis attributes 60.5% of PCE variance to absorber defect density as a first‐order effect and 17.8% to higher‐order parameter interactions. Absorber thickness and acceptor doping show near‐zero first‐order but total‐order indices of 2.5% and 6.9%, their effects reverse sign across the domain, so a single one‐at‐a‐time sweep cannot fully characterize them. All candidate configurations, from joint and one‐at‐a‐time optimization, were generated on the surrogate and then simulated in SCAPS‐1D, which showed a 0.9‐percentage‐point over‐prediction of the surrogate's joint optimum. After identical refinement within SCAPS‐1D, the best one‐at‐a‐time candidate reached 27.39% within the search restrictions (thickness ≤ 0.8 µm, defect density ≥ 10 1 5 cm − 3 ). That is 0.52 percentage points above the refined joint candidate and 8.9 points above the 18.52% reference. Surrogate‐proposed optima must therefore be validated within the originating simulator, and reported optima considered provisional pending such verification.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: